Venrock Adviser, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001615982

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHealth TiltHigh Turnover how tags are computed

Q2 2024 · 35 positions · Total reported value $1.57B · Top-10 concentration 64.6% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 35.1% · 4 new · 5 cut · 4 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +24.9% · vs SPY +10.0% · Prev Value $2.68B — last quarter positions weighted by this quarter price moves · ranking

In its Q2 2024 13F filing, Venrock Adviser, LLC disclosed 35 equity positions with a combined reported value of $1.57B. The filing implies a focused portfolio: its ten largest positions account for 64.6% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2024 were APGE ($334.21M), ELVN ($94.10M), FDMT ($92.36M). By sector, the heaviest allocations are Health Care 60.0%, Materials 0.0%. Versus the prior quarter, allocation shifted toward Health Care (+7.1pp) and away from Other (-6.9pp).

Versus the prior quarter, Venrock Adviser, LLC opened 4 new positions, trimmed 5 and fully exited 4, a turnover rate of 35.1% of positions. The portfolio's overlap with the prior quarter was 66% of names.

The largest new positions opened in Q2 2024 were ERAS ($38.27M), CGEM ($24.07M), ZURA ($21.08M).

Of the 4 positions fully exited versus the prior quarter, the largest were HLVX ($34.51M), CELC ($20.95M), IMTX ($18.39M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2024)

  • ERAS ERASCA INC · $38.27M
  • CGEM CULLINAN THERAPEUTICS INC · $24.07M
  • ZURA ZURA BIO · $21.08M
  • PCSC PERCEPTIVE CAP SOLUTIONS COR · $7.54M
  • ABIO ARCA BIOPHARMA INC · $3.32M
  • CASIF Chugai Pharmaceutical Co Ltd · $614.27K

Fully Exited (vs previous quarter)

  • HLVX HILLEVAX INC · prev qtr: $34.51M
  • CELC CELCUITY INC · prev qtr: $20.95M
  • IMTX IMMATICS N.V · prev qtr: $18.39M
  • LYRA LYRA THERAPEUTICS INC · prev qtr: $16.02M
  • CGON CG ONCOLOGY INC · prev qtr: $15.37M
  • MLYS MINERALYS THERAPEUTICS INC · prev qtr: $7.17M
  • SLRN ACELYRIN INC · prev qtr: $6.33M
  • EYPT EYEPOINT INC · prev qtr: $5.17M

Insider Transactions (Form 4)

Latest Venrock Adviser, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Venrock Adviser, LLC is an SEC-registered 13F filer based in New York, NY, United States. As of Q2 2026 it reported 33 US equity positions with a combined value of $3.30B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-79382 (status: Approved), registered 2014-04-09
  • Regulatory AUM (Form ADV): $4.50B as of 2026-04-28
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 7 private funds, of which 1 hedge funds

Portfolio Structure

  • 33 positions · $3.30B reported value (Q2 2026)
  • Top 10 holdings = 80.4% of reported value
  • Largest position: APGE (APOGEE THERAPEUTICS INC) at 34.2%
  • Average position size: $99.94M

Sector Tilt

  • Health Care 65.7%
  • Financials 0.1%
  • (classified holdings cover 66% of value)

Quarterly Activity

  • Q2 2026: 4 new, 5 added, 5 reduced, 4 exited
  • 19 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 60.0%
Materials 0.0%
Other 39.9%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 8.49M $334.21M 21.28%
21.28%
Hold
2 4.03M $94.10M 5.99%
5.99%
Hold
3 4.40M $92.36M 5.88%
5.88%
Hold
4 12.76M $87.30M 5.56%
5.56%
Hold
5 2.17M $76.72M 4.89%
4.89%
Hold
6 1.26M $74.74M 4.76%
4.76%
Reduce
7 6.25M $73.62M 4.69%
4.69%
Hold
8 3.40M $63.84M 4.07%
4.07%
Hold
9 2.69M $63.13M 4.02%
4.02%
Add
10 2.09M $54.20M 3.45%
3.45%
Hold
11 3.88M $50.51M 3.22%
3.22%
Hold
12 5.68M $47.92M 3.05%
3.05%
Add
13 9.54M $44.57M 2.84%
2.84%
Add
14 16.22M $38.27M 2.44%
2.44%
New
15 3.61M $32.84M 2.09%
2.09%
Hold
16 1.82M $32.75M 2.08%
2.08%
Hold
17 4.39M $31.07M 1.98%
1.98%
Hold
18 706.13K $29.21M 1.86%
1.86%
Hold
19 2.83M $26.65M 1.70%
1.70%
Add
20 1.38M $24.07M 1.53%
1.53%
New
21 3.41M $23.22M 1.48%
1.48%
Hold
22 11.33M $22.77M 1.45%
1.45%
Hold
23 6.02M $21.08M 1.34%
1.34%
New
24 9.00M $20.16M 1.28%
1.28%
Hold
25 1.35M $17.79M 1.13%
1.13%
Hold
26 627.79K $16.71M 1.06%
1.06%
Hold
27 5.56M $14.44M 0.92%
0.92%
Hold
28 5.39M $13.74M 0.88%
0.88%
Add
29 1.56M $11.70M 0.74%
0.74%
Hold
30 3.42M $10.20M 0.65%
0.65%
Hold
31 1.47M $10.06M 0.64%
0.64%
Reduce
32 750.00K $7.54M 0.48%
0.48%
New
33 1.56M $4.82M 0.31%
0.31%
Hold
34 866.38K $3.32M 0.21%
0.21%
New
35 111.69K $614.27K 0.04%
0.04%
New

FAQ

What did Venrock Adviser, LLC buy in 2024-Q2?

In its 2024-Q2 13F filing, Venrock Adviser, LLC reported 35 equity positions worth $1.57B in aggregate; its largest disclosed positions were APGE ($334.21M), ELVN ($94.10M), FDMT ($92.36M).

How large is Venrock Adviser, LLC's portfolio?

Venrock Adviser, LLC reported $1.57B of long equity holdings across 35 positions as of 2024-Q2. Top-10 holdings account for 64.6% of reported value.

What is Venrock Adviser, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/venrock-adviser/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →